<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013698</url>
  </required_header>
  <id_info>
    <org_study_id>ABIVENT</org_study_id>
    <nct_id>NCT04013698</nct_id>
  </id_info>
  <brief_title>Influence of Respiratory Mechanics on Brain-specific Monitoring in Brain-injured Patients</brief_title>
  <acronym>ABIVENT</acronym>
  <official_title>Effects of Chest Wall and Lung Elastances on Intracranial Pressure and Brain-specific Multimodal Monitoring in Ventilated Brain Injured Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Piquilloud Imboden Lise</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increase in intracranial pressure (ICP) could be associated with increase in positive&#xD;
      end-expiratory pressure (PEEP) level. Data are however disparate and interactions between&#xD;
      ventilation with high PEEP and intracranial circulation are still debated. Individual&#xD;
      patient's chest wall elastance could have a key role in determining the effects of PEEP on&#xD;
      ICP, since it dictates which proportion of the applied PEEP is transmitted to the pleural&#xD;
      space, thus increasing central venous pressure (CVP) and reducing cerebral venous return.&#xD;
      Measurement of esophageal pressure with a dedicated probe allows partitioning of respiratory&#xD;
      system elastance into its lung and chest wall components, thus permitting to study this&#xD;
      phenomenon. Multimodal intracranial monitoring permits to study the effects of PEEP on more&#xD;
      advanced brain-specific indices such as brain tissue oxygen (PtiO2), cerebral microdialysis&#xD;
      data, transcranial doppler ultrasound-derived flow measurements and automated pupillometry,&#xD;
      besides ICP.&#xD;
&#xD;
      This study aims to test the association between the ratio of chest wall to respiratory system&#xD;
      elastance and PEEP-induced variations in ICP and brain-specific multimodal monitoring&#xD;
      indices. This study will evaluate the relative role of other selected measures of respiratory&#xD;
      mechanics, hemodynamic variables and intracranial compliance, in order to establish the role&#xD;
      of individual respiratory mechanics in the interplay of physiological factors affecting the&#xD;
      effects of positive pressure ventilation on the brain.&#xD;
&#xD;
      Patients will undergo two periods of ventilation at two different levels of PEEP (5 and 15&#xD;
      cmH2O) in a randomized cross-over order. At the end of each period, cardiorespiratory&#xD;
      clinical data, ICP and other advanced multimodal neuromonitoring data (brain tissue oxygen&#xD;
      tension, cerebral microdyalisis analytes, transcranial doppler ultrasound and automated&#xD;
      infrared pupillometry data) will be collected. Systematic respiratory mechanics assessment&#xD;
      (including calculation of chest wall and lung elastances and estimation of the amount of&#xD;
      recruitment versus overdistension due to PEEP by means of a single-breath derecruitment&#xD;
      trial), echocardiography and arterial blood gas analysis will be performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Due to the COVID epidemics, starting with patient recruitement was not possible.&#xD;
  </why_stopped>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Actual">November 2, 2020</completion_date>
  <primary_completion_date type="Actual">November 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Patients included will receive volume assist-control ventilation with PEEP set at 5 cmH2O and 15 cmH2O in a randomized order (crossover design). Each setting will be applied during 45 minutes.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between Ers/Ecw and change in ICP between the two PEEP levels</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Respiratory mechanics; intracranial pressure monitoring&#xD;
Ers/Ecw = chest wall to respiratory system elastances ratio; ICP = intracranial pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between Ecw/Ers and the following neuromonitoring indices at the two PEEP levels: PtiO2, LPR, NPI; MFV, DFV and PI.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Respiratory mechanics; brain tissue oxygen tension; cerebral microdyalisis analytes; automated infrared pupillometry; transcranial doppler ultrasound&#xD;
Ers/Ecw = chest wall to respiratory system elastances ratio; PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index; MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the two different levels of PEEP on NPI.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Automated infrared pupillometry&#xD;
NPI = neurological pupil index&#xD;
PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the two different levels of PEEP on the following transcranial doppler ultrasound variables: MFV, DFV and PI.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Transcranial doppler ultrasound&#xD;
MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the two different levels of PEEP on LPR.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Cerebral microdyalisis analytes&#xD;
LPR = lactate/pyruvate ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the two different levels of PEEP on PtiO2.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Brain tissue oxygen tension.&#xD;
PtiO2 = brain tissue oxygen tension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the two different levels of PEEP on the following intravascular pressures: CVP, MAP, CPP.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Invasive intravascular pressures.&#xD;
CVP = central venous pressure; MAP = mean arterial pressure; CPP = cerebral perfusion pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the two different levels of PEEP on the following echocardiographic measurements: LVOT VTI, CO.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Echocardiography.&#xD;
LVOT VTI = left ventricle outflow tract velocity-time integral; CO = cardiac output (echocardiographically estimated).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of the two different levels of PEEP on the dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Administered drugs and fluids.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Ers/Ecw and the following parameters at the two PEEP levels: LVOT VTI, CO; CVP, MAP, CPP; dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Respiratory mechanics; echocardiography; invasive intravascular pressures; administered drugs and fluids&#xD;
LVOT VTI = left ventricle outflow tract velocity-time integral; CO = cardiac output (echocardiographically estimated); CVP = central venous pressure; MAP = mean arterial pressure; CPP = cerebral perfusion pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Pes_end-exp and the following parameters at the two PEEP levels: ICP, PtiO2, LPR, NPI, MFV, DFV, PI; CVP, MAP, CPP, LVOT VTI, CO, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Respiratory mechanics; intracranial pressure monitoring, Brain tissue oxygen tension; cerebral microdyalisis analytes; automated infrared pupillometry; transcranial doppler ultrasound; Echocardiography; invasive intravascular pressures; administered drugs and fluids.&#xD;
ICP = intracranial pressure; PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index; MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index; CVP = central venous pressure; MAP = mean arterial pressure; CPP = cerebral perfusion pressure; LVOT VTI = left ventricle outflow tract velocity-time integral; CO = cardiac output (echocardiographically estimated)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Rec/PEEPvol and the following parameters at the two PEEP levels: ICP, PtiO2, LPR, NPI, MFV, DFV, PI; CVP, MAP, CPP, LVOT VTI, CO, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Respiratory mechanics; intracranial pressure monitoring, Brain tissue oxygen tension; cerebral microdyalisis analytes; automated infrared pupillometry; transcranial doppler ultrasound; Echocardiography; invasive intravascular pressures; administered drugs and fluids.&#xD;
Rec/PEEPvol = recruited volume to PEEP-related volume ratio; ICP = intracranial pressure; PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index; MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index; CVP = central venous pressure; MAP = mean arterial pressure; CPP = cerebral perfusion pressure; LVOT VTI = left ventricle outflow tract velocity-time integral; CO = cardiac output (echocardiographically estimated)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Vd/Vt and the following parameters at the two PEEP levels: ICP, PtiO2, LPR, NPI, MFV, DFV, PI; CPP</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Respiratory mechanics; intracranial pressure monitoring, brain tissue oxygen tension; cerebral microdyalisis analytes; automated infrared pupillometry; transcranial doppler ultrasound; invasive intravascular pressures.&#xD;
Vd/Vt = dead space to tidal volume ratio; ICP = intracranial pressure; PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index; MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index; CVP = central venous pressure; CPP = cerebral perfusion pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between baseline PI at transcranial doppler ultrasound and the following parameters at the two PEEP levels: ICP, PtiO2, LPR, NPI, MFV, DFV, PI; LVOT VTI, CO, MAP, CPP.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Intracranial pressure monitoring, Brain tissue oxygen tension; cerebral microdyalisis analytes; automated infrared pupillometry; transcranial doppler ultrasound; Echocardiography; invasive intravascular pressures.&#xD;
PI = pulsatility index; ICP = intracranial pressure; PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index; MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index; LVOT VTI = left ventricle outflow tract velocity-time integral; CO = cardiac output (echocardiographically estimated); MAP = mean arterial pressure; CPP = cerebral perfusion pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between CVP and the following parameters at the two PEEP levels : ICP, PtiO2, LPR, NPI, MFV, DFV, PI; LVOT VTI, CO, MAP, CPP, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Intracranial pressure monitoring, Brain tissue oxygen tension; cerebral microdyalisis analytes; automated infrared pupillometry; transcranial doppler ultrasound; Echocardiography; invasive intravascular pressures; administered drugs and fluids.&#xD;
CVP = central venous pressure; ICP = intracranial pressure; PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index; MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index; LVOT VTI = left ventricle outflow tract velocity-time integral; CO = cardiac output (echocardiographically estimated); MAP = mean arterial pressure; CPP = cerebral perfusion pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between LVOT VTI and the following parameters at the two PEEP levels: PtiO2, LPR, NPI, MFV, DFV, PI; MAP, CPP, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Brain tissue oxygen tension; cerebral microdyalisis analytes; automated infrared pupillometry; transcranial doppler ultrasound; echocardiography, invasive intravascular pressures; administered drugs and fluids.&#xD;
LVOT VTI = left ventricle outflow tract velocity-time integral; PtiO2 = brain tissue oxygen tension; LPR = lactate/pyruvate ratio; NPI = neurological pupil index; MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index; MAP = mean arterial pressure; CPP = cerebral perfusion pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between PtiO2 and the following parameters at the two PEEP levels: ICP, MAP, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Intracranial pressure monitoring, brain tissue oxygen tension; invasive intravascular pressures; administered drugs and fluids.&#xD;
PtiO2 = brain tissue oxygen tension; ICP = intracranial pressure; MAP = mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between LPR and the following parameters at the two PEEP levels: ICP, MAP, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Intracranial pressure monitoring, cerebral microdyalisis analytes; invasive intravascular pressures; administered drugs and fluids.&#xD;
LPR = lactate/pyruvate ratio; ICP = intracranial pressure; MAP = mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between NPI and the following parameters at the two PEEP levels: ICP, MAP, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Intracranial pressure monitoring, automated infrared pupillometry; invasive intravascular pressures; administered drugs and fluids.&#xD;
NPI = neurological pupil index; ICP = intracranial pressure; MAP = mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between doppler indices (MFV, DFV and PI) and the following parameters at the two PEEP levels: ICP, MAP, dose of vasopressors/inotropes and volume of fluid boluses administered.</measure>
    <time_frame>Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes</time_frame>
    <description>Intracranial pressure monitoring, transcranial doppler ultrasound; invasive intravascular pressures; administered drugs and fluids.&#xD;
MFV = mean flow velocity; DFV = diastolic flow velocity; PI = pulsatility index; ICP = intracranial pressure; MAP = mean arterial pressure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Brain Injuries</condition>
  <arm_group>
    <arm_group_label>PEEP level 5 cmH2O to 15 cmH2O</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PEEP level 15 cmH2O to 5 cmH2O</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PEEP level 5 cmH2O</intervention_name>
    <description>PEEP level set for 45 minutes</description>
    <arm_group_label>PEEP level 15 cmH2O to 5 cmH2O</arm_group_label>
    <arm_group_label>PEEP level 5 cmH2O to 15 cmH2O</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PEEP level 15 cmH2O</intervention_name>
    <description>PEEP level set for 45 minutes</description>
    <arm_group_label>PEEP level 15 cmH2O to 5 cmH2O</arm_group_label>
    <arm_group_label>PEEP level 5 cmH2O to 15 cmH2O</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Acute brain injury of any etiology requiring multimodal brain monitoring&#xD;
             (intraparenchymal intracranial pressure, brain-tissue oxygen tension and cerebral&#xD;
             microdialysis)&#xD;
&#xD;
          -  Controlled mechanical ventilation via endotracheal tube&#xD;
&#xD;
          -  Patient needing deep sedation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  contraindications to nasogastric probe placement: basilar skull or significant&#xD;
             naso-facial fractures, significant esophageal or gastric trauma or bleeding, previous&#xD;
             esophageal surgery, significant bleeding diathesis (spontaneous aPTT &gt; 60 sec, PT &lt;&#xD;
             40%, INR &gt; 1.8, platelets &lt; 50000/mm3), known esophageal or gastric varices&#xD;
&#xD;
          -  decompressive craniectomy&#xD;
&#xD;
          -  intracranial pressure monitoring method other than intraparenchymal (e.g. connected to&#xD;
             external ventricular drain)&#xD;
&#xD;
          -  severe relevant physiological instability contraindicating an increase in PEEP: severe&#xD;
             baseline intracranial pressure elevation (&gt; 20 mmHg), severe hemodynamic instability&#xD;
             (defined as norepinephrine requirements &gt; 0.5 Î¼g/kg/min or cardiogenic shock, defined&#xD;
             as any use of dobutamine)&#xD;
&#xD;
          -  conditions that interfere with accurate measurements of respiratory mechanics:&#xD;
             bronchopleural fistula, pneumothorax.&#xD;
&#xD;
          -  Withhold of life-sustaining therapy for medical reasons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lise Piquilloud, MER&amp;PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lausanne University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lausanne University Hospitals</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 10, 2019</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Piquilloud Imboden Lise</investigator_full_name>
    <investigator_title>Sponsor-Investigator</investigator_title>
  </responsible_party>
  <keyword>ventilation</keyword>
  <keyword>brain injuries</keyword>
  <keyword>PEEP</keyword>
  <keyword>esophageal pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

